RT30

RT30 is a research compound containing LY3437943. RT30 is an investigational triple-receptor compound studied for its interaction with GIP, GLP-1, and glucagon receptor signaling pathways. Research involving RT30 has focused on receptor-binding activity, incretin-related pathway studies, metabolic signaling models, and glucagon-associated cellular response mechanisms in controlled laboratory settings.